跳至主要内容
临床试验/ISRCTN13721429
ISRCTN13721429进行中(未招募)Unknown

A group-based behavioural intervention for weight management (PROGROUP) versus usual care in adults accessing NHS Tier 3 weight management services for treatment of severe obesity: a multi-centre, two-arm, individually randomised controlled, assessor-blinded, adaptive superiority trial with parallel process evaluation and health economic evaluation

niversity Hospitals Plymouth NHS Trust0 个研究点目标入组 990 人开始时间: 2023年8月25日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
990

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients must satisfy these criteria to be considered for the study:
  • 1. Referred to the T3WMS within the last 6 months OR if referred to the T3WMS more than 6 months ago there is a clinically confirmed weight and BMI within the last 6 months.
  • 2. In individuals with with a South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family background, Body Mass Index > = 37.5 kg/m2 or Body Mass Index > = 32.5 kg/m2 with at least one significant comorbidity.
  • In all other individuals, Body Mass Index > = 40 kg/m2 or Body Mass Index > = 35 kg/m2 with at least one significant comorbidity.
  • Patients must satisfy all of the following criteria to be enrolled in the study:
  • 1. Registered with the T3WMC
  • 2. In individuals with with a South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family background, Body Mass Index > = 37.5 kg/m² or Body Mass Index > = 32.5 kg/m² with at least one significant comorbidity at the point of consent.
  • In all other individuals, Body Mass Index > = 40 kg/m² or Body Mass Index > = 35 kg/m² with at least one significant comorbidity at the point of consent.
  • 3.Aged > = 18 years
  • 4. Willing to be randomised to either PROGROUP or usual care
  • 5. Willing to be weighed on at least three occasions (baseline, 6 months and 12 months)
  • 6. Willing to provide blood samples and blood pressure readings on three occasions (baseline, 6 months and 12 months)
  • 7. Considered suitable for group-based care
  • 8. Have capacity to consent

排除标准

  • Patients who meet any of the following criteria will be excluded from study participation:
  • 1. Already undergone bariatric surgery
  • 2.Are scheduled, or have made their own plans, to undergo bariatric surgery during the course of the trial.
  • 3. Currently taking the following pharmacotherapy for the indication of weight loss: Semaglutide, Liraglutide, Orlistat, or any off-licence weight-reducing pharmacotherapy such as the stimulant appetite suppressants phentermine and diethylpropion. Commencing these medications from six months post-randomisation is allowable, consistent with NICE guideline 189, 1.8.1: ‘consider pharmacological treatment only after dietary, exercise and behavioural approaches have been started and evaluated’.
  • 4. Currently engaged in any other weight management trial
  • 5. Unwilling or unable to attend group sessions
  • 6. Intending to relocate outside the geographical region during the trial period
  • 7. Participants who have significant difficulties in adequate understanding of English, or a sensory impairment, such that they are unable to sufficiently understand/access the trial documentation or engage in group sessions, in the absence of a local provision of translated materials or communication aids.

研究者

发起方
niversity Hospitals Plymouth NHS Trust

相似试验